tradingkey.logo

Gelteq Ltd

GELS
查看详细走势图
0.897USD
+0.038+4.37%
收盘 12/19, 16:00美东报价延迟15分钟
9.61M总市值
亏损市盈率 TTM

Gelteq Ltd

0.897
+0.038+4.37%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+4.37%

5天

-11.14%

1月

+1.26%

6月

-43.91%

今年开始到现在

-61.31%

1年

-65.35%

查看详细走势图

TradingKey Gelteq Ltd股票评分

单位: USD 更新时间: 2025-10-27

操作建议

当前估值合理,机构持股占比非常高,目前股价在压力位和支撑位之间,可以做区间波段操作。

Gelteq Ltd评分

相关信息

行业排名
136 / 173
全市场排名
564 / 4682
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Gelteq Ltd亮点

亮点风险
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
估值高估
公司最新PE估值-2.15,处于3年历史高位
机构加仓
最新机构持股105.80K股,环比增加0.61%

Gelteq Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Gelteq Ltd简介

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
公司代码GELS
公司Gelteq Ltd
CEOGivoni (Nathan Jacob)
网址https://www.gelteq.com

常见问题

Gelteq Ltd(GELS)的当前股价是多少?

Gelteq Ltd(GELS)的当前股价是 0.897。

Gelteq Ltd的股票代码是什么?

Gelteq Ltd的股票代码是GELS。

Gelteq Ltd股票的52周最高点是多少?

Gelteq Ltd股票的52周最高点是4.110。

Gelteq Ltd股票的52周最低点是多少?

Gelteq Ltd股票的52周最低点是0.770。

Gelteq Ltd的市值是多少?

Gelteq Ltd的市值是9.61M。

Gelteq Ltd的净利润是多少?

Gelteq Ltd的净利润为-6.65M。

现在Gelteq Ltd(GELS)的股票是买入、持有还是卖出?

根据分析师评级,Gelteq Ltd(GELS)的总体评级为--,目标价格为--。

Gelteq Ltd(GELS)股票的每股收益(EPS TTM)是多少

Gelteq Ltd(GELS)股票的每股收益(EPS TTM)是-1.070。
KeyAI